quantisnow
FeedTopReportsPricing
⌘K
Live feed
18:03:14·57d
INSIDERFiling
Xeris Biopharma Holdings Inc. logo

Officer Nguyen Anh Tu covered exercise/tax liability with 29,300 shares, decreasing direct ownership by 7% to 395,023 units (SEC Form 4)

XERS· Xeris Biopharma Holdings Inc.
Health Care
Original source

Companies

  • XERS
    Xeris Biopharma Holdings Inc.
    Health Care

Recent analyst ratings

  • Dec 9UpdateBarclays$9.00
  • Aug 12UpdateH.C. Wainwright$10.00
  • Nov 11UpdatePiper Sandler$3.00
  • Mar 28UpdateOppenheimer$5.00
  • Aug 28UpdateCraig Hallum$4.50
  • Oct 21UpdateJefferies$4.00

Related

  • SEC18h
    SEC Form DEFA14A filed by Xeris Biopharma Holdings Inc.
  • SEC18h
    SEC Form DEF 14A filed by Xeris Biopharma Holdings Inc.
  • PR1d
    Xeris Biopharma to Report First Quarter 2026 Financial Results on May 7, 2026
  • SEC2d
    Xeris Biopharma Holdings Inc. filed SEC Form 8-K: Leadership Update
  • INSIDER20d
    SEC Form 4 filed by Hecht Beth
  • PR20d
    Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
  • INSIDER22d
    SEC Form 4 filed by Brady James Aloysius
  • SEC27d
    Amendment: SEC Form SCHEDULE 13G/A filed by Xeris Biopharma Holdings Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022